Innovative yttrium-90 transforms liver cancer treatment

Yttrium-90 radioisotopes produced at the University of Missouri Research Reactor are extending and improving the lives of patients with liver cancer.

Graphic shows microscopic Yttrium-90 radioisotopes produced at the University of Missouri Research Reactor in a liver.


March 28, 2024

Liver cancer is one of the deadliest forms of the disease, and the American Cancer Society estimates a 71 percent mortality rate for patients in the U.S. diagnosed with primary liver and intrahepatic bile duct cancer.